About Positrigo

Our vision is to make functional imaging accessible for people worldwide and create a lasting social impact.
We advance clinical routine and enable research in diagnostics , treatment monitoring and the development of new therapies.
Positrigo makes functional imaging scalable – imaging everyone!

Careers at Positrigo

Are you interested to join Positrigo and find a job with purpose?
Visit the Positrigo Career Site to browse the most recent positions.

Board of Directors

Urs Suter

Chairman of the Board

Urs Suter

Chairman of the Board,

 

Former CEO and chairman of the board of directors at Siemens Healthcare AG and Healthcare Diagnostics GmbH.

Prof. em. Dr. Alfred Buck

Co-Founder, Member of the Board, Advisor

Prof. em. Dr. Alfred Buck

Co-Founder, Member of the Board, Advisor

 

Co-Founder of Swisstrace and former Professor and Head of NeuroPET at the University Hospital Zurich. Buck helps the team build a device from clinicians, for clinicians.

Dr. Jean-Pierre Rosat

Member of the Board

Dr. Jean-Pierre Rosat

Member of the Board

General partner and Founder at 4FO Venture Partners.

Alex Vamvakas

Member of the Board

Alex Vamvakas

Member of the Board

Alex is involved in private equity and venture capital investments. He is passionate about technology and innovation, and he holds a diploma from the National Technical University of Athens and an MSc from Imperial College London. He leverages his engineering and entrepreneurial background to identify successful founders and to support portfolio companies throughout their journey.

Dr. Max Ahnen

Co-Founder, Member of the Board

Dr. Max Ahnen

Co-Founder, Member of the Board

 

After studying physics at the TU Munich, the Max Planck Institute for Physics, and Durham University, Max became a PhD student on gamma-ray Cherenkov telescopes at the ETH Zurich Institute for Particle Physics. Upon finishing his PhD, Max, together with Jannis, was awarded the 2017 ETH Pioneer Fellowship for the Brain PET Project. VentureKick and Forbes Europe 30 under 30 followed.

Advisory Board

Prof. Paul G. Unschuld

Division of Geriatric Psychiatry, Geneva University Hospitals (HUG)

Prof. Paul G. Unschuld

Advisor

Prof. Unschuld is at the Division of Geriatric Psychiatry, Geneva University Hospitals (HUG), Switzerland.

Univ.-Prof. Dr. med. Osama Sabri

Director and Chairman of the Department of Nuclear Medicine, University Hospital Leipzig

Univ.-Prof. Dr. med. Osama Sabri

Advisor

Director and Chairman of the Department of Nuclear Medicine, University Hospital Leipzig, Germany; Internationally recognized, leading expert/key opinion leader in Neuro Nuclear Medicine and molecular imaging of neurodegenerative/–psychiatric Disorders; Principle Investigator in a multitude of clinical trials from phase 0 to phase III in that field; Speaker of a variety of projects in the adoption of new hybrid cross-modality PET imaging methods including but not limited to PET and PET/MRI in interdisciplinary clinical routine and research settings including PET-tracer development.

Prof. Dr.-Ing. Bernhard Sattler

Head Medical Physics, Department of Nuclear Medicine, University Hospital Leipzig

Prof. Dr.-Ing. Bernhard Sattler

Advisor

Head of Medical Physics/Radiation Protection, Department of Nuclear Medicine, University Hospital Leipzig, Germany; Honorary professor of medical engineering; Approved Medical Physics Expert in radiation protection, handling of unsealed radionuclides in medicine and running a cyclotron; Internationally recognized expert in physical and technical support of the implementation and adoption of hybrid cross-modality PET imaging techniques in interdisciplinary clinical routine and research workflows; Full member and assessor of the European Examination Board of the European Federation of Physics in Medicine.

Prof. Harry Tsoumpas

Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen

Prof. Harry Tsoumpas

Nuclear Physicist and Biomedical Engineer working in the field of PET imaging, where he utilises mathematics and physics together with computational methods and software for the development of cutting-edge approaches that will significantly evolve medicine and healthcare towards earlier diagnosis and treatment of diseases.

 

Prof. Bruno Weber

Institute of Pharmacology and Toxicology, University of Zurich

Prof. Bruno Weber

Co-Founder, Advisor

Co-Founder of Swisstrace and Professor at the Institute for Pharmacology and Toxicology at University of Zurich, Weber brings together expertise from PET imaging, biology, and business.

Prof. Dr. Günther Dissertori

Rector-elect ETH Zurich

Prof. Dr. Günther Dissertori

Co-Founder, Advisor

 

Professor for Particle Physics at ETH Zurich, Dissertori brings 20+ years of experience in particle physics into our project. The current head of the Institute of Particle Physics and Astrophysics at ETH and former Deputy Spokesperson of the CMS experiment at CERN.

Prof. em. Dr. Alfred Buck

Co-Founder, Member of the Board, Advisor

Prof. em. Dr. Alfred Buck

Co-Founder, Member of the Board, Advisor

 

Co-Founder of Swisstrace and former Professor and Head of NeuroPET at the University Hospital Zurich. Buck helps the team build a device from clinicians, for clinicians.

Prof. Dr. Kris Thielemans

Institute of Nuclear Medicine
University College London

Prof. Dr. Kris Thielemans

Advisor

 

Internationally recognized expert in data processing techniques for PET, with previous experience in Theoretical Physics. Finding innovative and practically achievable ways to improve quantitative and diagnostic image quality. Advisor to a world-wide team of scientists to develop, implement and test new algorithms, and to present results to stakeholders. Kris is Professor in Medical Imaging Physics at UCL and founder of Algorithms and Software Consulting Ltd.

Partners

Can we help?

We are looking forward to showing you our technology either virtually or on site.

Get in Touch